Health is changing fast. We make it make sense.

Clinical Research

Rare genetic disorder Treated Before Birth in the womb: A Bold Step Forward

Researchers have achieved a groundbreaking prenatal treatment for spinal muscular atrophy (SMA) by administering the drug risdiplam to a mother, resulting in her now two-year-old daughter thriving without disease symptoms. This case highlights the potential of early interventions in preventing genetic disorders, paving the way for future advancements in prenatal healthcare.

April 30, 2025

•

1–2 minutes

Sources and References

Live Science. “Deadly Motor-Neuron Disease Treated in the Womb in World 1st.” Live Science, 2025, https://www.livescience.com/health/medicine-drugs/deadly-motor-neuron-disease-treated-in-the-womb-in-world-1st.

IFLScience. “Rare Genetic Motor Neuron Disease Treated In Womb For The First Time.” IFLScience, 2025, https://www.iflscience.com/rare-genetic-motor-neuron-disease-treated-in-womb-for-the-first-time-78178.

New Atlas. “Infant’s Genetic Muscle Disorder Improved by Treating Pregnant Mother.” New Atlas, 2025, https://newatlas.com/disease/spinal-muscular-atrophy-infant-treated-in-utero/.

St. Jude Children’s Research Hospital. “Promising Results from First Prenatal Therapy for Spinal Muscular Atrophy.” St. Jude Newsroom, 2025, https://www.stjude.org/media-resources/news-releases/2025-medicine-science-news/promising-results-from-first-prenatal-therapy-for-spinal-muscular-atrophy.html

UpNEX Health

Leave a comment Cancel reply

Get the UpNEX Health Brief.

A concise, evidence-based briefing on the health stories worth knowing, sent once a month.

You might also like…